Neuro-Sys has developed specific preclinical in vitro models of CNS (Central Nervous System) and PNS (Peripheral Nervous System) diseases. These models allow our team of scientific experts to understand the mode of action of molecules used in the treatment of neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, Multiple sclerosis, Huntington's disease, Adrenoleukodystrophy, Multiple System Atrophy, Charcot-Marie Tooth ...). Neuro-Sys is a privileged partner in the pharmaceutical industry and for biotechnological companies developing neuroprotective and neurorehabilitation molecules.
Neuro-Sys has also defined a unique model of the blood-brain barrier. Our scientific experts are now able to say which active compound can cross this barrier and have an active effect(s) on the brain. These innovations enable Neuro-Sys to provide a unique array of services to pharmaceutical laboratories, biotechs and now, nutraceutical companies.
To best meet the needs and high expectations of our customers, Neuro-Sys has equipped itself with a green-extraction laboratory. This laboratory has an analytical platform that allows us to take any given plant and determine its chemical and neuropharmacological profile. Concretely, this means that the client can determine the qualities of any plant species, whether or not it acts on a neurodegenerative disease, and if so, which one and the effect it may have, how it works. For example, if a plant contains two or three effective compounds, our scientists can determine the most relevant ratios. These results are then tested on neurons that are grown in vitro.
All of this is possible not only thanks to the highly sophisticated equipment that we have acquired but also because we combine this equipment with the skills and know-how of our scientific experts (pharmacists, pharmacologists and phytochemists), enabling them to have a unique positioning and added value in this field.
Our analytical services also allow customers a cost-effective way to get the pharmacological and analytical profiles of their products.
Drug Development services: a new department dedicated to supporting your projects
With our latest developments, Neuro-Sys now offers an unparalleled opportunity for nutraceutical development companies to access high level studies and consulting services for their products that target aging diseases.
Our clients benefit from a personalised support and services during the development of their programmes from the discovery phase to phase two clinical studies. With considerable experience in the development of multiple drug candidates, our team of experts offers a Development Plan according to all regulatory and non-regulatory requirements, specific to our clients' drug candidate and the possibility to assist them in writing the regulatory documentation (IB, IMPD...) to correspond with the regulatory authorities or ethic committees for clinical trial authorisation.
We can also assist you in writing your research documents (abstract, patent, publication, etc)